Background: Understanding the relationship between dose, lung exposure, and drug efficacy continues to be a challenging aspect of inhaled drug development. An experimental inhalation platform was developed using mometasone furoate to link rodent lung exposure to its in vivo pharmacodynamic (PD) effects.
Methods: We assessed the effect of mometasone delivered directly to the lung in two different rodent PD models of lung inflammation.